Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Prediction of New Onset Diabetes Mellitus After Transplantation (NODAT) in Renal Transplantation: Use of Oral Glucose Tolerance Test (OGTT) and Fasting Plasma Glucose (FPG).

NCT00442988 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT00442988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Prediction of New Onset Diabetes Mellitus After Transplantation (NODAT) in Renal Transplantation: Use of Oral Glucose Tolerance Test (OGTT) and Fasting Plasma Glucose (FPG).
Lead sponsor
KU Leuven
Phase
Observational
Overall status
Completed
Start date
October 31, 2000
Completion date
October 31, 2005
Enrollment
360
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation